In a study, patients who underwent salvage cryotherapy for radiorecurrent prostate cancer had cancer-specific and metastasis-free survival rates of 81% and 78%, respectively, at 12 years.
Men on active surveillance for prostate cancer progress to treatment sooner if they undergo multiparametric MRI to identify clinically significant tumors.
Study of patients who underwent radical cystectomy for bladder cancer found that those who used statins had improved overall and cancer-specific survival.
Among patients with non-muscle-invasive bladder cancer, those with diabetes and HbA1c levels below 7% have shorter progression-free survival.
Cytoreductive nephrectomy (CN) by itself for metastatic renal cell carcinoma is associated with a 43% decreased risk of death compared with CN plus targeted therapy.
In a population-based study, PN was associated with improved cancer-specific survival by 56%.
Radical prostatectomy and ablation for salvage treatment of radiorecurrent prostate cancer do not differ significant with regard to cancer-specific and metastasis-free survival, a study found.
Radical prostatectomy (RP) for localized prostate cancer after a period of active surveillance offers overall and cancer-specific survival similar to that of men who undergo upfront RP.
Patients with high-risk stones wider than 7.0 mm or wider than 5 mm located in the proximal-middle ureter should be offered early surgery, according to researchers.
In a study, urologists were the top prescribers of codeine, the most commonly used opioid.
Please login or register first to view this content.
